Dolor por cáncer

Margarita Eugenia Araujo Navarrete; Miguel Ángel Genis-Rondero

doi:10.47924/neurotarget2015230

Authors

Margarita Eugenia Araujo Navarrete Cancer Center, ABC Medical Center, Mexico City, Mexico.
Miguel Ángel Genis-Rondero Hospital de Traumatología “Dr. Victorio de La Fuente Narváez”, en Magdalena de las Salinas, del Instituto Mexicano del Seguro Social (IMSS), Distrito Federal, México.

DOI:

https://doi.org/10.47924/neurotarget2015230

Keywords:

cancer pain, diagnostic; analgesic, treatment, evidence, recommendation

Abstract

Analgesic treatment is an integral part of the care of patients with oncological disease. Scientific knowledge establishes guidelines for the efficient management of pain, with the purpose of improving the quality of life and prevent the suffering of the patient and their families. Evaluation of the characteristics of the disease, response to treatment and possible risks, allows to propose specific schemes, according to the circumstances of each patient, which have proven their benefit. Dissemination of these results can meet the demand of one of the leading causes of morbidity and mortality in the world. Research and education in all aspects of cancer, are still essential. The importance of recognizing the need for control of pain as a human right, which is still being ignored, compels us to insist on the possibility of override the fear in the prescription of drugs for each patient.

Metrics

Metrics Loading ...

Author Biographies

Margarita Eugenia Araujo Navarrete, Cancer Center, ABC Medical Center, Mexico City, Mexico.

Medical specialist in Anesthesiology, Algology and Palliative Care. Former President of the Mexican Association for the Study and Treatment of Pain (AMETD).
Member of the hospital bioethics committee of the ABC Medical Center (The American British Cowdray Medical Center IAP), Mexico City.
Coordinator of the clinic specialized in the care of the terminally ill, at the Cancer Center, ABC Medical Center, Mexico City, Mexico.

Miguel Ángel Genis-Rondero, Hospital de Traumatología “Dr. Victorio de La Fuente Narváez”, en Magdalena de las Salinas, del Instituto Mexicano del Seguro Social (IMSS), Distrito Federal, México.

Medical specialist in Anesthesiology. High Specialty Medical Unit, of the Traumatology Hospital “Dr. Victorio de La Fuente Narváez”, in Magdalena de las Salinas, of the Mexican Social Security Institute (IMSS), Federal District, Mexico. Doctor specializing in Algology. Head of the Pain and Palliative Care Clinic, at the General Hospital of Tlalnepantla “Valle Ceylan”, of the Health Institute of the State of Mexico, Mexico. Former President of the Mexican Association for the Study and Treatment of Pain (AMETD), former Treasurer of the Latin American Federation of Associations for the Study of Pain (FEDELAT).

References

Koller A, Miaskowski C, De Geest S, Opitz O, Spichiger E. A systematic evaluation of content, structure, and efficacy of interventions to improve patients’ self-managementof cancer pain. J Pain Symptom Manage. 2012;44(2):264-84.

Luckett T, Davidson PM, Green A, Boyle F, Stubbs J, Lovell M. Assessment and management of adult cancer pain: a systematic review and synthesis of recent qualitative studies aimed at developing insights for managing barriers and optimizing facilitators within a comprehensive framework of patient care. J Pain Symptom Manage. 2013;46(2):229-53.

Paice JA, Ferrell B. The management of cancer pain. CA Cancer J Clin. 2011;61(3):157-82.

Stewart BW, Wild CP, editors. World Cancer Report 2014. Lyon, France: Word Health Organization International Agency for Research on Cancer; 2014.

de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607-15.

Institutos Nacionales de la Salud de EE. UU. (NIH); Instituto Nacional del Cáncer. Estadificación del cáncer [Internet]. Bethesda (Maryland), EE. UU.: NIH; 2015 [citado 11 may 2015]. Disponible en: http://www.cancer.gov/espanol/cancer/diagnostico-estadificacion/estadificacion/hoja-informativa-estadificacion.

Gajjar K, Martin-Hirsch PP, Bryant A. Pain relief for women with cervical intraepithelial neoplasia undergoing colposcopy treatment. Cochrane Database Syst Rev. 2012;10:CD006120.

Word Health Organization (WHO). Cancer related pain relief: with a guide to opioid availability. 2nd ed. Geneva, Switzerland: WHO; 1996.

Jho HJ, Myung SK, Chang YJ, Kim DH, Ko DH. Efficacy of pain education in cancer patients: a meta-analysis of randomized controlled trials. Support Care Cancer. 2013;21(7):1963-71.

Sheinfeld Gorin S, Krebs P, Badr H, Janke EA, Jim HS, Spring B, et al. Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. J Clin Oncol. 2012;30(5):539-47.

Dworkin RH, O’Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc, 2010; 85(3):S3-S14

Dworkin RH. Introduction: recommendations for the diagnosis, assessment, and treatment of neuropathic pain. Am J Med. 2009; 122(10):S1-S2

Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-73.

Kopf A, Patel NB, editores. Guía para manejo del dolor en condiciones de bajos recursos. Washington D. C., EE. UU.: IASP; 2010. p. 139-73.

WHO. WHO Normative Guidelines on Pain Management. Geneva, Switzerland: WHO; 2007. p. 18-24.

Grossman SA, Dunbar EM, Nesbit SA. Cancer pain management in the 21st century. Oncology (Williston Park). 2006;20(11):1333-9; discussion 1340-2, 1347-8, 1351.

Paice JA. Pain at the end of life. In: Ferrell BR, Coyle N, editors. Oxford Textbook of Palliative Nursing. 3rd ed. New York, NY: Oxford University Press; 2010. p. 161-85.

Mitra F, Chowdhury S, Shelley M, Williams G. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain. Pain Med. 2013;14(1):75-83.

Przeklasa-Muszyńska A, Dobrogowski J. Transdermal buprenorphine in the treatment of cancer and non-cancer pain the results of multicenter studies in Poland. Pharmacol Rep. 2011;63(4):935-48.

Kress HG, Koch ED, Kosturski H, Steup A, Karcher K, Lange B, et al. Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain. Pain Physician. 2014;17(4):329-43.

Schröder W, Vry JD, Tzschentke TM, Jahnel U, Christoph T. Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain. Eur J Pain. 2010;14(8):814-21.

Mercadante S, Porzio G, Adile C, Aielli F, Cortegiani A, Dickenson A, et al. Tapentadol at medium to high doses in patients previously receiving strong opioids for the management ofcancer pain. Curr Med Res Opin. 2014;30(10):2063-8.

Imanaka K, Tominaga Y, Etropolski M, Ohashi H, Hirose K, Matsumura T. Ready conversion of patients with well-controlled, moderate to severe, chronic malignant tumor related pain on other opioids to tapentadol extended release. Clin Drug Investig. 2014;34(7):501-11.

Imanaka K, Tominaga Y, Etropolski M, van Hove I, Ohsaka M, Wanibe M, et al. Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain. Curr Med Res Opin. 2013;29(10):1399-409.

Mercadante S, Porzio G, Aielli F, Adile C, Verna L, Ficorella C, et al. Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids. Curr Med Res Opin. 2013;29(6):661-6.

Sullivan MD, Robinson JP. Antidepressant and anticonvulsant medication for chronic pain. Phys Med Rehabil Clin N Am. 2006;17(2):381-400, vi-vii.

Kalso E. Pharmacological management of pain: anticonvulsants, antidepressants, and adjuvants analgesics. In: International Association for the Study of Pain (IASP). Pain an updated review: refresher course syllabus. Seatle, Washington: IASP Press; 2005. p. 19-29.

American Cancer Society. Guide to controlling cancer pain [Internet]. Atlanta, Georgia: American Cancer Society; 2014 [citado 11 may 2015]. Disponible en: http://www.cancer.org/treatment/treatments and side effects/physical side effects/pain/pain diary/pain-control-pdf.

Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 2011;(3):CD007519.

Albi-Feldzer A, Mouret-Fourme E E, Hamouda S, Motamed C, Dubois PY, Jouanneau L, et al. A double-blind randomized trial of wound and intercostal space infiltration with ropivacaine during breast cancer surgery: effects on chronic postoperative pain. Anesthesiology. 2013;118(2):318-26.

Plancarte R, Guajardo J, Meneses-Garcia A, Hernandez-Porras C, Chejne-Gomez F, Medina-Santillan R, et al. Clinical benefits of femoroplasty: a nonsurgical alternative for the management of femoral metastases. Pain Physician. 2014;17(3):227-34.

Domínguez L, Arredondo JL, Castañón JA, García E, Granados J, Guinto G, et al. Dolor óseo de origen oncológico. Bol Inform Clin Terapeut. 2014;23(2):4-6.

National Opioid Use Guideline Group (NOUGG). Canadian guideline for safe and effective use of opioids for chronic non-cancer pain [Internet]. Canada: NOUGG; 2010 [citado 11 may 2015]. Disponible en: http://nationalpaincentre.mcmaster.ca/opioid/

Hurlow A, Bennett MI, Robb KA, Johnson MI, Simpson KH, Oxberry SG. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database Syst Rev. 2012;3:CD006276.

Levy MH, Smith T, Alvarez-Perez A, Back A, Baker JN, Block S, et al. Palliative care, version 1.2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2014;12(10):1379-88.